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ABSTRACT 
Aim: The aim of this systematic review was to evaluate the current reported efficacy and the mortality rate of SEMS 
treatment in uncontrolled bleeding patients. 
 Background: Esophageal variceal bleeding (EVB) represents a life threatening pathology. Despite the adequate 
pharmacologic and endoscopic treatment, continuous or recurrent bleeding, named as uncontrolled bleeding, occurs in 
10-20% of cases. A new removable, covered, and self-expanding metal stent (SEMS) was proposed to control the 
variceal bleeding.  
Materials and methods: The study was conducted according to the PRISMA statement. Studies were identified by 
searching MEDLINE (1989-present) and SCOPUS (1989-present) databases. The last search was run on 01 July 2015.  
Results: Nine studies (period range=2002-2015) met the inclusion criteria and were included in quantitative analysis. 
High rate of SEMS efficacy in controling acute bleeding was observed, with a reported percentage ranging from 77.7 to 
100%. In 10% to 20% of patients, re-bleeding occurred with SEMS in situ. Stent deployment was successful in 77.8% to 
100% of patients while 11 to 36.5% of patients experienced stent migration.  
Conclusion: SEMS could be effective and safe in control EVB and can be proposed as a reliable option to ballon 
tamponed for patient stabilization and as a bridging to other therapeutic approach.  
Keywords: Nonselective β-blockers, TIPSS, Endoscopic band ligation, Uncontrolled bleeding, Self-
expanding metal stent. 
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Introduction 
  1Esophageal variceal bleeding (EVB) 
represents a life threatening pathology associated 
with a six-week mortality rate of 20% following 
the initial bleeding episode (1, 2). Prevention of 
re-bleeding can be achieved using non-selective β-
blockers (NSBBs), endoscopic band ligation 
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(EBL), a combination of NSBBs and EBL, as well 
as transjugular intrahepatic portosystemic stent 
shunt (TIPSS). Despite the adequate 
pharmacologic and endoscopic treatment, 
continuous or recurrent bleeding, named as 
uncontrolled bleeding, occurs in 10-20% of cases 
(3). Sengstaken-blakemore balloon tamponade 
(BT), may control the initial variceal hemorrhage 
in > 80% of patients, leading to a high 
complication rate (4, 5). Early TIPSS placement 
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and related technical improvements (6, 7) reduced 
treatment failure in these patients. The current 
available techniques in the event of uncontrolled 
bleeding are not getting enough. Recently, a new 
treatment option, represented by removable, 
covered, self-expanding metal stent (SEMS) was 
suggested to control acute refractory variceal 
bleeding (8). Recently, SEMS have been proposed 
as a safer option than BT in uncontrolled 
esophageal variceal bleeding (3) even if the level 
of evidence is still low since data derive mainly 
from case-series.  
The aim of this systematic review was to collect 
all the currently available studies utilizing SEMS 
for the treatment of acute esophageal variceal 
bleeding as the first line therapy or as a rescue 
therapy in order to asses efficacy and feasibility of 
SEMS in control bleeding and their safety.  
 
Material and Methods  
The study was conducted according to the 
PRISMA statement (9). We included only English 
uncontrolled esophageal variceal bleeding. No 
publication date or publication study restrictions 
were imposed. Participants of any age and sex were 
considered. The primary outcome measure was the 
correct positioning rate, and the secondary outcome 
was the failure to control bleeding rate as defined in 
the Baveno IV Consensus Workshop (10). We 
excluded abstracts, review articles, meta-analyses, 
and editorials. Studies were identified by searching 
Pubmed (1989-present) and SCOPUS (1989-
present) databases. The last search was run on 01 
July 2015. Search criteria are summarized in Figure 
1. We used the following search terms for all 
databases: “variceal bleeding SEMS; AND/OR? 
oesophageal stent variceal bleeding”. Eligibility 
assessment was performed independently in a 
blinded standardized manner by four reviewers. 
One review author extracted the following data 
from included studies: type of study, the number of 
participants, primary and secondary outcomes, as 
well as a diagnostic tool used. A senior investigator 
resolved disagreements between reviewers. The 
information extracted were: reference with 
acquisition data range year, study classification, 
number of patients enrolled, SEMS type, the 
presence of active bleeding, effectiveness of 
immediate hemostasis and rebleeding/migration 
rate (Table 1).  
 
 
 
Figure 1. Flow chart of systematic review. 
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Results 
Study selection  
The search in PubMed and Scopus provided a 
total of 82 citations. After adjusting for duplicates, 
56 articles remained. Of these, 51 were discarded 
because the title and/or the abstract were off-topic. 
With respect to the remaining five studies, it 
appears necessary to add four articles by citations. 
Finally, nine studies met the inclusion criteria and 
were included in the analysis (Figure 1) (11-19). 
Study characteristics   
All selected papers were single center case 
series and most of them belonged to the European 
area. Almost all studies employed SEMS as a 
rescue therapy after failure of combined 
endoscopy and pharmacology treatments or even 
after BT. The data collection period range was 
2002-2014. Although many papers on 
uncontrolled bleeding have been published in the 
US, the studies concerning SEMS were performed 
in Austria (16, 17), Egypt (11), Netherlands (13), 
Moldavia (18) and Germany (19).  
Patients’ characteristics 
One hundred twenty four patients were 
enrolled into the nine studies selected for review 
(92 male; mean age 56 years; age range 18-87). 
All the studies included cirrhotic patients with at 
least Child B cirrhosis, except for two patients 
with Child-Pugh score A.  Median Meld was 27 
(range 8-40). The main inclusion criterion was the 
presence of uncontrolled esophageal varices 
bleeding with or without BT before stenting 
insertion.  
SEMS characteristics and related data   
Excluding the Hubmann study (16), in which 
Choo Stent NES−18−080−070 (M.I. Tech Co., 
Ltd) and Boubela-Danis esophageal stents were 
used, most studies used the SX-Ella Danis stent 
(Ella-CS, Hradec Kralove, Czech Republic) as a 
removable, covered, and self-expanding metal 
stent to treat uncontrolled bleeding. This SEMS 
can be deployed in the lower esophagus without 
traditional radiological or endoscopic assistance. 
Two studies (11, 18) reported  the amount of  time 
spent for stent application, which was about 4-10 
minutes. A high rate of SEMS efficacy to control 
acute bleeding was observed, with a reported 
percentage ranging from 77.7 to 100%. In 10% to 
20% of patients re-bleeding occurred, even though 
SEMS was correctly in place. Stent deployment 
was successful in 77.8% to 100% of patients while 
11 to 80% of patients experienced stent migration. 
Stent remained “in situ” for a few hours to 214 
days.  The migration of the stent was not related to 
the re-bleeding. Intra-procedural mortality was not 
reported. Severe adverse complications were 
extremely rare, while the main complication 
reported at removal was the development of 
esophagus distal ulcerations.  
 
Discussion 
Combined treatment with vasoactive drugs, 
prophylactic antibiotics, endoscopic techniques, 
and together with hemodynamic resuscitation, is 
the recommended standard care for patients with 
acute variceal bleeding (8). However, treatment 
failure occurs in about 10 to 15% of patients. 
Management of failures includes repeated 
endoscopic treatment.  Moreover, in most severe 
patients, TIPSS placement has to be considered 
as a rescue therapy (8). Although TIPSS insertion 
is highly effective with control of bleeding, it is 
still complicated by high mortality mainly due to 
a worsening in liver function (24). For that 
reason, an early TIPSS placement, within 72 
hours (ideally <24 hours) is suggested in patients 
with variceal bleeding and at high-risk of 
treatment failure (8, 25-27) since it has been 
shown to not only prevented recurrent bleeding 
but also improved survival (25, 26). However, 
until definitive treatment can be instituted, 
temporary “bridge treatments” need to be applied 
in patients who present an uncontrolled bleeding.  
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Table 1. Characteristics of the included studies using Self Expandable metal stents (SEMS)=SX-ELLA Stent Danis. 
Author 
Study 
period 
Geographic 
Area 
Classification Patients 
Characteristics 
 
 
Number 
of Active 
Bleedings
Treatment 
approach 
 prior to 
stenting 
Number of 
Immediate 
bleeding 
controls 
Number of 
Rebleeding 
events  with
stent “in 
situ” 
Stent  
Duration 
(days,range) 
Number of 
Successful 
Stent 
Deployment 
Number of 
Migration/ 
Complications at 
removal 
Hubmann R 
2002-2005 
Austria 
Case Series* 
Single center 
20 pts (18M) 
Median Age 52 
yrs (27-87) 
Child B: 8; Child 
C:12 
20 Numbers of 
BL=11 
Numbers of 
BL+ST=5 
Numbers of 
BL+BT=1 
20 (100%) 0 1-14 20 
(100%) 
5 (25%)**/1 
small ulceration 
in the distal 
esophagus 
Zehetner J 
2003-2006 
Austria 
Case Series 
Single center 
34 pts 
Median Age 56 
yrs (32-91) 
Child B 13; 
Child C: 21 
34 Numbers of 
BL=21 
Numbers of 
ST=8 
Numbers of BT: 
6 
34 (100%) 0 1-14 Not reported 7 (20.5%)/1 slight 
ulceration in the 
distal esophagus 
Wright G 
2007-2008 
UK 
Case Series 
Single center 
10 pts (9M) 
Median Age 
49,6 yrs (14-39) 
Median MELD 
score25 (14-39) 
9 Numbers of 
endoscopic 
hemostasis 
treatments =5 
Numbers of 
BT=3 
7 (77.8%) 1 (10%) 6-14 9 
(100%) 
2 (22.2%) 
Complicated 
with  esophageal 
Perforation/1  
ulceration in the 
distal  esophagus
Dechêne A 
2007-2011 
Germany 
Case Series 
Single center 
8 pts (6M) 
Mean Age 
63±11 
Median MELD 
score31 (16-41) 
Child C=8 
9 Numbers of 
BL=6 
Numbers of 
ST+BL+BT=2 
9 (100%) 0 7-14 9 
(100%) 
1 (11%)/none
Zahkaria 
MS 
2008-2009 
Egypt 
Case Series 
Single center 
16pts (14M) 
Mean Age 56±6 
Child A=2, 
Child B=8; 
Child C=6 
16 None 14 (87.5%) 0 2-4 15 
(93.7%) 
6 (36.5%)/1 deep  
ulceration in the 
distal  esophagus 
Fierz FC 
2010-2011 
Switzerland 
Case Series 
Multicentric 
7pts (5M) 
Median Age56 
yrs (41-68) 
Child B=2; 
Child C=5 
Median MELD 
score29 (11-37) 
9 Numbers of 
BL=4 
Numbers of 
BL+ST=2 
8 (88.9%) 0 12 h-5 days 7 
(77.8%) 
2 (22.2%)/none
Ghidirim 
Gh.P 
2010-2012 
Moldavia 
Case series 
Single center 
14 pts (8M) 
Median Age 51 
(range 32-69) 
Mean Child: 
9.5±0.4 
Mean MELD 
score: 17.7±1.7  
9 Number of 
BL=14 
14 (100%) 0 18h-7 days 14 
(100%) 
5 
41.6%/not 
reported 
Holster IL 
2012 
Netherlands 
Case Series 
Single center 
5 pts (3M) 
Median Age 58 
yrs (48-78) 
Median MELD 
score 21 (11-28) 
5 Numbers of 
BL=5 
5 (100%) 1 (20%) 6-214 Not reported 1 (20%)/None
Mὒller M 
2011-2014 
Germany 
Case Series 
Single center 
10 pts (8M); 
Median Age: 6 
(range 43-79) 
 
Child B=6; 
Child C=4 
Median MELD 
Score 15.5 (8-
27)  
1 Not reported 10 (100%) 0 5-24 days 10 (100%) 8 (80%)/ 2 
ulcerations  
Band Ligation=BT; Sclerotherapy: ST; Ballon Tamponade:BT;  *Two patients with Choo stents, three patients Ella±Boubela stents, 
and 15 patients with Ella±Danis stents; ** One patients with Choo stent, two patients with Ella±Boubela stents, and two patients with 
Ella±Danis stents 
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The BT, performed by skilled specialists, is an 
effective method to control the acute variceal 
bleeding in achieving hemostasis in 61% of 
patients (20). On the other hand, the BT can be 
adopted as a life-saving procedure by non-
specialists in unprotected areas. This may explain 
the high rate of complications and the relatively 
low rate of effectiveness.  
However, considering the high rate of possible 
serious complications caused by the blind 
technique, the use of BT has recently been 
discouraged in the last Baveno consensus (8). For 
this reason, other inserting techniques (21) and 
devices were proposed. 
Currently, a promising alternative is 
represented by covered SEMS. Since 2002 until 
today, nine studies examined the efficacy and 
safety of stents as treatment for uncontrolled 
bleeding. This method follows the rationale of 
BT exploiting the potential of the stent to 
compress varices with the radial force as initially 
used for palliation of malignant stenosis. 
Although the first prototype needed the 
radiological guide during positioning, a 
subsequent development bypassed this 
disadvantage using a specific insertion device 
(16). 
Waiting for the next publication of 
randomized multicenter studies (22), available 
data suggest that SEMS placement allows a safe 
bridging from the acute bleeding episode to the 
therapeutic procedures, being able to induce an 
effective control of the esophageal variceal 
bleeding (23). However, stent deployment may 
be problematic and stent migrations may occur. 
Furthermore, removal of the stent may lead to the 
development of ulceration of the distal 
esophagus. Learning curve for the endoscopy 
placement and removal of the stents has not been 
reported, so if an increasing specialist skill would 
lead to an increase in the rate of correct stents’ 
placement and a reduction of stents’ migration 
remains an open question.  
In conclusions, SEMS is effective and safe in 
control EVB and can be proposed as a reliable 
option to BT for patient’s stabilization and as a 
bridging to other therapeutic approach. Further 
studies, including a large number of consecutive 
patients and non-specialists performed 
procedures are needed to increase the reliability 
of the reported data. 
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